Sufficient production of geranylgeraniol is required to maintain Endotoxin tolerance in macrophages

Journal of Lipid Research

Volumn 54, Issue 12, 2013, Pages 3430-3437

  Ye, Jin ^a   Kim, Jinyong ^a   Lee, Joon No ^a,b   Ye, James ^a   Hao, Rosy ^a   Debose Boyd, Russell ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Wonkwang University   (South Korea)

Author keywords

HMG CoA reductase; Interleukin 1 ; Malt1

Indexed keywords

ENDOTOXIN; GERANYLGERANIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MALT1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME INHIBITION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

HMG-COA REDUCTASE; INTERLEUKIN 1-Β; MALT1;

ANIMALS; DITERPENES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL;

EID: 84887887604     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M042549     Document Type: Article

References (35)

1. Biswas, S. K., and E. Lopez-Collazo. 2009. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30:475-487.
2. Cavaillon, J. M., C. Adrie, C. Fitting, and M. Adib-Conquy. 2003. Endotoxin tolerance: is there a clinical relevance? J. Endotoxin Res. 9:101-107. (Pubitemid 36603684)
3. Goldstein, J. L., and M. S. Brown. 1990. Regulation of the mevalonate pathway. Nature. 343:425-430.
4. Im, S. S., L. Yousef, C. Blaschitz, J. Liu, R. Edwards, S. Young, M. Raffatellu, and T. Osborne. 2011. Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab. 13:540-549.
5. Dennis, E. A., R. A. Deems, R. Harkewicz, O. Quehenberger, H. A. Brown, S. B. Milne, D. S. Myers, C. K. Glass, G. Hardiman, D. Reichart, et al. 2010. A mouse macrophage lipidome. J. Biol. Chem. 285:39976-39985.
6. Andreyev, A. Y, E. Fahy, Z. Guan, S. Kelly, X. Li, J. G. McDonald, S. Milne, D. Myers, H. Park, A. Ryan, et al. 2010. Subcellular organelle lipidomics in TLR-4-activated macrophages. J. Lipid Res. 51:2785-2797.
7. Spann, N. J., L. X. Garmire, J. G. McDonald, D. S. Myers, S. B. Milne, N. Shibata, D. Reichart, J. N. Fox, I. Shaked, D. Heudobler, et al. 2012. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell. 151:138-152.
8. Im, S. S., and T. F. Osborne. 2011. Liver X receptors in atherosclerosis and inflammation. Circ. Res. 108:996-1001.
9. Frenkel, J., G. T. Rijkers, S. H. L. Mandey, S. W. M. Buurman, S. M. Houten, R. J. A. Wanders, H. R. Waterham, and W. Kuis. 2002. Lack of isoprenoid products raises ex vivo interleukin-113 secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum. 46:2794-2803. (Pubitemid 36118945)
10. Houten, S. M., J. Frenkel, and H. R. Waterham. 2003. Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation. Cell. Mol. Life Sci. 60:1118-1134. (Pubitemid 36791916)
11. Mandey, S. H., L. M. Kuijk, J. Frenkel, and H. R. Waterham. 2006. A role for geranylgeranylation in interleukin-113 secretion. Arthritis Rheum. 54:3690-3695.
12. Giriwono, P. E., H. Shirakawa, Y. Ohsaki, S. Hata, H. Kuriyama, S. Sato, T. Goto, and M. Komai. 2013. Dietary supplementation with geranylgeraniol suppresses lipopolysaccharide-induced inflammation via inhibition of nuclear factor-KB activation in rats. Eur. J. Nutr. 52:1191-1199.
13. Liscum, L., K. L. Luskey, D. J. Chin, Y K. Ho, J. L. Goldstein, and M. S. Brown. 1983. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and its mRNA in rat liver as studied with a monoclonal antibody and a cDNA probe. J. Biol. Chem. 258:8450-8455.
14. Gong, Y., J. N. Lee, P. C. W. Lee, J. L. Goldstein, M. S. Brown, and J. Ye. 2006. Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake. Cell Metab. 3:15-24.
15. Zhang, X., R. Goncalves, and D. Mosser. 2008. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. 83:14.1.1-14.1.7.
16. Liang, G., J. Yang, J. D. Horton, R. E. Hammer, J. L. Goldstein, and M. S. Brown. 2002. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J. Biol. Chem. 277:9520-9528. (Pubitemid 34953041)
17. Sever, N., T. Yang, M. S. Brown, J. L. Goldstein, and R. A. DeBose-Boyd. 2003. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol. Cell. 11:25-33. (Pubitemid 36126588)
18. del Prete, M. J., R. Vernal, H. Dolznig, E. W. Müllner, and J. A Garcia-Sanz. 2007. Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments. RNA. 13:414-421. (Pubitemid 46327544)
19. Adams, C. M., J. Reitz, J. K. De Brabander, J. D. Feramisco, L. Li, M. S. Brown, and J. L. Goldstein. 2004. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J. Biol. Chem. 279:52772-52780. (Pubitemid 39656653)
20. Horton, J. D., N. A. Shah, J. A. Warrington, N. N. Anderson, S. W. Park, M. S. Brown, and J. L. Goldstein. 2003. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. USA. 100:12027-12032. (Pubitemid 37271509)
21. Tam, S. P., L. Brissette, R. Ramharack, and R. G. Deeley. 1991. Differences between the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor in human hepatoma cells and fibroblasts reside primarily at the translational and post-translational levels. J. Biol. Chem. 266:16764-16773. (Pubitemid 21907864)
22. Sen, R. 2011. The origins of NF-kB. Nat. Immunol. 12:686-688.
23. Skaug, B., X. Jiang, and Z. J. Chen. 2009. The role of ubiquitin in NF-kB regulatory pathways. Annu. Rev. Biochem. 78:769-796.
24. Deng, L., C. Wang, E. Spencer, L. Yang, A. Braun, J. You, C. Slaughter, C. Pickart, and Z. J. Chen. 2000. Activation of the IkB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 103:351-361.
25. Sun, L., L. Deng, C. K. Ea, Z. P. Xia, and Z. J. Chen. 2004. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell. 14:289-301. (Pubitemid 38591401)
26. Thome, M. 2008. Multifunctional roles for MALT1 in T-cell activation. Nat. Rev. Immunol. 8:495-500. (Pubitemid 351913678)
27. Zhang, F. L., and P. J. Casey. 1996. Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65:241-269. (Pubitemid 26250610)
28. Khan, O. M., M. X. Ibrahim, I. M. Jonsson, C. Karlsson, M. Liu, A. K. Sjogren, F. J. Olofsson, M. Brisslert, S. Andersson, C. Ohlsson, et al. 2011. Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice. J. Clin. Invest. 121:628-639.
29. Nakanishi, M., J. L. Goldstein, and M. S. Brown. 1988. Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. J. Biol. Chem. 263:: 8929-8937.
30. Gaylor, J. R. 1981. Formation of sterols in animals. In Biosynthesis of Isoprenoid Compounds. Vol. 1. J. W. Porter and S. L. Spurgeon, editors. John Wiley and Sons, New York. 481-543.
31. Kastner, D. L., I. Aksentijevich, and R. Goldbach-Mansky. 2010. Autoinflammatory disease reloaded: a clinical perspective. Cell. 140:784-790.
32. Houten, S. M., W. Kuis, M. Duran, T. J. de Koning, A. van Royen-Kerkhof, G. J. Romeijn, J. Frenkel, L. Dorland, M. M. J. de Barse, W. A. R. Huijbers, et al. 1999. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat. Genet. 22:175-177. (Pubitemid 29264813)
33. Houten, S. M., R. J. A. Wanders, and H. R. Waterham. 2000. Biochemical and genetic aspects of mevalonate kinase and its deficiency. Biochim. Biophys. Acta. 1529:19-32.
34. Vastert, S. J., W. Kuis, and A. A. Grom. 2009. Systemic JIA: new developments in the understanding of the pathophysiology and therapy. Best Pract. Res. Clin. Rheumatol. 23:655-664.
35. Ghatak, A., O. Faheem, and P. D. Thompson. 2010. The genetics of statin-induced myopathy. Atherosclerosis. 210:337-343.